Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...

Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

Current research into effective treatments for gastroparesis is focused on agonists of motilin, a peptide hormone that accelerates gastric emptying. McCallum and colleagues studied whether ...

This may cause persistent nausea and vomiting. The symptoms include constant nausea and vomiting. → Common treatment options → Questions to ask your doctor Gastroparesis is said to be caused by ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025Gimoti remains only approved drug shown to ...

Most of the time, doctors say, gastroparesis will improve after stopping the medication. But some people say that their ...

(NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, underscores its ...

Unfortunately, Mounjaro and similar medications have caused some people to experience serious complications, including gastroparesis, or stomach paralysis. For some patients who have experienced ...

Evoke Pharma (EVOK) underscores its commitment to patients and healthcare providers managing gastroparesis in light of FDA’s recent update ...

already included a warning label for people with severe gastroparesis and severe gastrointestinal disease. GLP-1s can be prescribed for weight loss and for diabetes treatment, as well as some ...

(RTTNews) - Evoke Pharma Inc. (EVOK), a pharmaceutical company focused on treatments for gastrointestinal diseases, announced on Tuesday that it has received notices of allowance for two ...